These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26154885)

  • 1. Synthesis and Evaluation of New Podophyllotoxin Derivatives with in Vitro Anticancer Activity.
    Cheng WH; Shang H; Niu C; Zhang ZH; Zhang LM; Chen H; Zou ZM
    Molecules; 2015 Jul; 20(7):12266-79. PubMed ID: 26154885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.
    Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J
    J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents.
    Cheng WH; Cao B; Shang H; Niu C; Zhang LM; Zhang ZH; Tian DL; Zhang S; Chen H; Zou ZM
    Eur J Med Chem; 2014 Oct; 85():498-507. PubMed ID: 25113878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 4β-triazole-podophyllotoxin derivatives by azide-alkyne cycloaddition and biological evaluation as potential antitumor agents.
    Chen H; Zuo S; Wang X; Tang X; Zhao M; Lu Y; Chen L; Liu J; Liu Y; Liu D; Zhang S; Li T
    Eur J Med Chem; 2011 Sep; 46(9):4709-14. PubMed ID: 21821321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
    Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
    Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis and antitumor activity of novel indole podophyllotoxin derivatives].
    Tian DL; Liang CP; Liang J; Chen H
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2532-2537. PubMed ID: 31359720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
    Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
    Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytotoxic activity of novel derivatives of 4'-demethylepipodophyllotoxin.
    Chen SW; Tian X; Tu YQ
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5063-6. PubMed ID: 15380199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on novel 4beta-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxins as potential anticancer agents.
    Bhat BA; Reddy PB; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
    Eur J Med Chem; 2008 Oct; 43(10):2067-72. PubMed ID: 17988764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
    Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
    Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and potent cytotoxic activity of novel podophyllotoxin derivatives.
    Li WQ; Wang XL; Qian K; Liu YQ; Wang CY; Yang L; Tian J; Morris-Natschke SL; Zhou XW; Lee KH
    Bioorg Med Chem; 2013 Apr; 21(8):2363-2369. PubMed ID: 23490151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents.
    Liu J; Cao B; Gao Y; Bai M; Mei X; Chen H; Jiang YG; Huang DJ
    J Asian Nat Prod Res; 2013 Sep; 15(9):985-92. PubMed ID: 23859462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds.
    Hyder I; Yedlapudi D; Kalivendi SV; Khazir J; Ismail T; Nalla N; Miryala S; Sampath Kumar HM
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2860-3. PubMed ID: 26022842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of d-ring modified acid hydrazide derivatives of podophyllotoxin and their anticancer studies as Tubulin inhibiting agents.
    Nerella S; Kankala S; Paidakula S; Gavaji B
    Bioorg Chem; 2020 Jan; 94():103384. PubMed ID: 31776036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
    Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
    Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
    Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
    Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin.
    Liu JF; Sang CY; Xu XH; Zhang LL; Yang X; Hui L; Zhang JB; Chen SW
    Eur J Med Chem; 2013 Jun; 64():621-8. PubMed ID: 23711769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of new 4β-anilino-4'-O-demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents.
    Wang L; Yang F; Yang X; Guan X; Hu C; Liu T; He Q; Yang B; Hu Y
    Eur J Med Chem; 2011 Jan; 46(1):285-96. PubMed ID: 21145139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of novel per-butyrylated glycosides of podophyllotoxin and its derivatives.
    Zi CT; Yang D; Dong FW; Li GT; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
    Bioorg Med Chem; 2015 Apr; 23(7):1437-46. PubMed ID: 25744190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives.
    Chengniu W; Zhonghua W; Yu Z; Chunyan N; Xiaodong Z; Li Z
    Arch Pharm (Weinheim); 2011 Nov; 344(11):735-40. PubMed ID: 21887802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.